US health insurer Cigna said on Thursday, March 8, it would buy pharmacy benefits manager Express Scripts for about US$52 billion; the latest deal in the sector aimed at tackling soaring healthcare costs.
US health insurer Cigna is close to buying St. Louis County-based pharmacy benefit manager Express Scripts, the Wall Street Journal reported late Wednesday, citing people familiar with the matter.
The terms of the potential deal were not released, but a deal could be announced anytime, the newspaper said. Express Scripts had a market value of US$41.43 billion as of Wednesday’s close, according to Thomson Reuters Eikon data.
Express Scripts spokesman Phil Blando declined to comment on the report Wednesday night, while Cigna could not be immediately reached for comment.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
DirecTV and Disney Resolve Dispute, Restore Programming for Subscribers
Sep 15, 2024 by
CPI
UK Antitrust Authority Raises Concerns Over Vodafone-Three Merger
Sep 15, 2024 by
CPI
Brazilian Supreme Court Lifts Freeze on Starlink Accounts, Transfers $3.3 Million to National Treasury
Sep 15, 2024 by
CPI
Steptoe Expands Antitrust Practice with Key London Hire
Sep 15, 2024 by
CPI
Instant Ad Auctions at the Heart of Google’s Federal Monopoly Case
Sep 15, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
Francisco Javier Núñez Melgoza
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
Julio Garcia
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
Alejandra Palacios Prieto
The Cost of Making COFECE Disappear
Sep 3, 2024 by
Mateo Fernández